Es gab 50 kürzliche Insider-Transaktionen für Pardes Biosciences, Inc. (PRDS), darunter 37 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $10.82M und die gesamten Insider-Verkäufe auf $13.2M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Auerbach Mark, Lobell J Jay, Wiggans Thomas G. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PRDS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-08-31 |
Auerbach Mark |
Director |
Aktienrückgabe |
37,500 |
$5.21 |
$195.38K |
- |
| 2023-08-31 |
Lobell J Jay |
Director |
Aktienrückgabe |
37,500 |
$5.21 |
$195.38K |
- |
| 2023-08-31 |
Wiggans Thomas G |
Chief Executive Officer |
Aktienrückgabe |
985,000 |
$6.36 |
$6.26M |
- |
| 2023-08-31 |
Henson Heidi |
Chief Financial Officer |
Aktienrückgabe |
125,000 |
$2.98 |
$372.5K |
- |
| 2023-08-31 |
Pottage John C Jr |
Director |
Aktienrückgabe |
75,000 |
$2.98 |
$223.5K |
- |
| 2023-08-31 |
Tananbaum James B. |
10 Percent Owner, Officer: President and CEO |
Aktienrückgabe |
75,000 |
$9.80 |
$735K |
- |
| 2023-08-31 |
Smaldone Alsup Laurie |
Director |
Aktienrückgabe |
75,000 |
$2.98 |
$223.5K |
- |
| 2023-08-31 |
Lopatin Uri A |
Director |
Aktienrückgabe |
421,000 |
$11.32 |
$4.77M |
- |
| 2023-08-31 |
Varney Michael David |
Director |
Aktienrückgabe |
37,500 |
$5.21 |
$195.38K |
- |
| 2023-08-31 |
Hamill Laura |
Director |
Aktienrückgabe |
37,500 |
$5.21 |
$195.38K |
- |
| 2023-08-31 |
Autor Deborah M. |
Director |
Aktienrückgabe |
37,500 |
$5.21 |
$195.38K |
- |
| 2023-08-31 |
Lacy Elizabeth H. |
General Counsel, Secretary |
Aktienrückgabe |
125,000 |
$2.98 |
$372.5K |
- |
| 2023-06-01 |
Auerbach Mark |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Lobell J Jay |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Pottage John C Jr |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Tananbaum James B. |
10 Percent Owner |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Smaldone Alsup Laurie |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Lopatin Uri A |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Varney Michael David |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Hamill Laura |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-06-01 |
Autor Deborah M. |
Director |
RSU-Zuteilung |
37,500 |
$1.87 |
$70.13K |
37,500 |
| 2023-04-05 |
Foresite Capital Management V, Llc |
10 Percent Owner |
Informierter Kauf |
773,952 |
$1.50 |
$1.16M |
13,583,762 |
| 2023-04-05 |
Foresite Capital Opportunity Management V, Llc |
10 Percent Owner |
Informierter Kauf |
773,952 |
$1.50 |
$1.16M |
8,773,134 |
| 2023-02-01 |
Wiggans Thomas G |
Chief Executive Officer |
RSU-Zuteilung |
562,500 |
$2.08 |
$1.17M |
562,500 |
| 2023-02-01 |
Henson Heidi |
Chief Financial Officer |
RSU-Zuteilung |
156,250 |
$2.08 |
$325K |
156,250 |
| 2023-02-01 |
Lacy Elizabeth H. |
General Counsel, Secretary |
RSU-Zuteilung |
156,250 |
$2.08 |
$325K |
156,250 |
| 2023-02-01 |
Brusky Sean P. |
Chief Commercial Officer |
RSU-Zuteilung |
156,250 |
$2.08 |
$325K |
156,250 |
| 2023-02-01 |
Kearney Brian |
Chief Development Officer |
RSU-Zuteilung |
156,250 |
$2.08 |
$325K |
156,250 |
| 2022-12-08 |
Brusky Sean P. |
Chief Commercial Officer |
Informierter Kauf |
21,000 |
$1.19 |
$24.99K |
21,000 |
| 2022-12-05 |
Wiggans Thomas G |
Chief Executive Officer |
Informierter Kauf |
12,500 |
$1.09 |
$13.63K |
50,000 |
| 2022-12-02 |
Wiggans Thomas G |
Chief Executive Officer |
Informierter Kauf |
12,500 |
$1.07 |
$13.38K |
37,500 |
| 2022-12-01 |
Wiggans Thomas G |
Chief Executive Officer |
Informierter Kauf |
25,000 |
$1.04 |
$26K |
25,000 |
| 2022-12-01 |
Foresite Capital Management V, Llc |
Director |
Informierter Kauf |
637,420 |
$0.85 |
$541.81K |
12,809,810 |
| 2022-09-14 |
Wiggans Thomas G |
Chief Executive Officer |
RSU-Zuteilung |
450,000 |
$2.98 |
$1.34M |
450,000 |
| 2022-09-14 |
Henson Heidi |
Chief Financial Officer |
RSU-Zuteilung |
125,000 |
$2.98 |
$372.5K |
125,000 |
| 2022-09-14 |
Pottage John C Jr |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-09-14 |
Pottage John C Jr |
Director |
RSU-Zuteilung |
75,000 |
$2.98 |
$223.5K |
75,000 |
| 2022-09-14 |
Smaldone Alsup Laurie |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-09-14 |
Smaldone Alsup Laurie |
Director |
RSU-Zuteilung |
75,000 |
$2.98 |
$223.5K |
75,000 |
| 2022-09-14 |
Tinmouth Brian Philippe |
Chief Bus. & Strategy Officer |
RSU-Zuteilung |
125,000 |
$2.98 |
$372.5K |
125,000 |
| 2022-09-14 |
Lacy Elizabeth H. |
General Counsel, Corporate Sec |
RSU-Zuteilung |
125,000 |
$2.98 |
$372.5K |
125,000 |
| 2022-09-14 |
Brusky Sean P. |
Chief Commercial Officer |
RSU-Zuteilung |
125,000 |
$2.98 |
$372.5K |
125,000 |
| 2022-09-14 |
Kearney Brian |
Chief Development Officer |
RSU-Zuteilung |
125,000 |
$2.98 |
$372.5K |
125,000 |
| 2022-07-19 |
Lobell J Jay |
Director |
Sonstige (Kauf) |
1,163,861 |
- |
- |
1,163,861 |
| 2022-06-08 |
Auerbach Mark |
Director |
RSU-Zuteilung |
37,500 |
$5.21 |
$195.38K |
37,500 |
| 2022-06-08 |
Lobell J Jay |
Director |
RSU-Zuteilung |
37,500 |
- |
- |
37,500 |
| 2022-06-08 |
Tananbaum James B. |
Director |
RSU-Zuteilung |
37,500 |
- |
- |
37,500 |
| 2022-06-08 |
Varney Michael David |
Director |
RSU-Zuteilung |
37,500 |
- |
- |
37,500 |
| 2022-06-08 |
Hamill Laura |
Director |
RSU-Zuteilung |
37,500 |
$5.21 |
$195.38K |
37,500 |
| 2022-06-08 |
Autor Deborah M. |
Director |
RSU-Zuteilung |
37,500 |
- |
- |
37,500 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall